MBio Technology Inc

M Bio Technology Inc.

M Bio Technology is seeking alliance partners, out-licensing, also for IND, preclinical and marketing.

 

KEY ACTIVITIES:

Vaccine

SECTOR:

Pharma

KEY WORDS:

Mycoplasma fermentans Infectious Diseases

TYPE OF ACTIVITIES:

discovery and development of innovative therapeutic strategy

Company Description:

M Bio Technology Inc. is a leading company focused on the discovery and development of innovative therapeutic strategy for Mycoplasma Infectous Diseases (MID).
They develop innovative vaccine (MID VaccineTM), diagnostics (MID PrismTM), precision therapy (MID Precision MedicineTM) for Mycoplasma Infectious Diseases (MID).

Type of Partnership Sought:

  1. License agreement 
  1. Commercial agency agreement 
  1. Research cooperation agreement

 

We use a selection of our own and third-party cookies on the pages of this website. If you choose "ACCEPT ALL", you consent to the use of all cookies. You can accept and reject individual cookie types.
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
Subscribe
Brussels
Tokyo
1 EUR = 173,140 JPY